Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 6

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Genitourinary 5Thoracic 3Dermatologic 2Plasma cell 1Other neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Breast Neoplasms 6392Neoplasms 408Ovarian Neoplasms 308Triple Negative Breast Neoplasms 286Prostatic Neoplasms 280Lung Neoplasms 271Colorectal Neoplasms 255Neoplasm Metastasis 254Carcinoma, Non-Small-Cell Lung 221Breast Neoplasms, Male 201Colonic Neoplasms 168Motor Activity 166Pancreatic Neoplasms 164Melanoma 157Carcinoma, Intraductal, Noninfiltrating 139Stomach Neoplasms 128Uterine Cervical Neoplasms 127Head and Neck Neoplasms 124Fatigue 104Breast Carcinoma In Situ 103Carcinoma, Ovarian Epithelial 98Endometrial Neoplasms 96Lymphedema 95Carcinoma, Renal Cell 94Urinary Bladder Neoplasms 93Pain 90Sarcoma 89Small Cell Lung Carcinoma 85Lymphoma 83Esophageal Neoplasms 81

Interventions

pertuzumab 1Trastuzumab 1Surgical Procedures, Operative 1Radiotherapy 1Injections, Subcutaneous 1Focus Groups 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Patient Preference × Breast × Clear all
NCT05415215 2026-02-10

ProHer

Hoffmann-La Roche

Phase 3 Completed
346 enrolled 20 charts
Breast

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT05970471 2025-12-12

IMPLICATION

Centre Hospitalier Universitaire de Besancon

Completed
167 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Patient Preference

NCT05573022 2025-11-17

IMPACTT

Vejle Hospital

Phase NA Completed
274 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Patient Participation, Patient Preference

NCT04936243 2022-12-20

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Dana-Farber Cancer Institute

Phase NA Completed
30 enrolled
BreastGenitourinary

Breast Neoplasms, Patient Participation, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

NCT02565017 2020-06-25

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Memorial Sloan Kettering Cancer Center

Completed
70 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms, Patient Preference

NCT00595218 2017-07-25

Patient Preference Survey for Radiation Oncologists

University of Pittsburgh

Phase NA Completed
500 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡